Invesco Gold & Special Minerals Fund A USD Acc vs UBS Lux Equity Fund Biotech USD

Invesco Gold & Special Minerals Fund A USD Acc vs UBS Lux Equity Fund Biotech USD

1. Invesco Gold & Special Minerals Fund A USD Acc

  • Verdipapir

    Invesco Gold & Special Minerals Fund A USD Acc

  • Gebyr

    2.00%

  • ISIN

    LU0505655562

  • Beholdninger

    7

2. UBS Lux Equity Fund Biotech USD

  • Verdipapir

    UBS Lux Equity Fund Biotech USD P-acc

  • Gebyr

    2.25%

  • ISIN

    LU0069152568

  • Beholdninger

    10

Fondsbeholdning

Vi har information om 11 beholdninger i Invesco Gold & Special Minerals Fund A USD Acc, hvor den største beholdningen er Northern Star Resources (4.93%), etterfulgt av Agnico Eagle Mines (3.84%) og Newmont (3.8%). Sammenligner vi med UBS Lux Equity Fund Biotech USD har vi der 14 beholdninger hvor Regeneron Pharmaceuticals er største beholdningen (10.04%), etterfulgt av Vertex (9.35%) og Moderna (9.21%).

Alle beholdninger

Her sammenligner vi beholdningene i Invesco Gold & Special Minerals Fund A USD Acc og UBS Lux Equity Fund Biotech USD.

Invesco Gold & Special Minerals Fund A USD Acc UBS Lux Equity Fund Biotech USD
1. Northern Star Resources Ltd
Australia
4.93 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Agnico Eagle Mines Ltd
Canada
3.84 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. Newmont Corp
USA
3.8 %
3. Moderna Inc
9.21 %
4. Artemis Gold Inc
Canada
3.24 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. K92 Mining Inc
Canada
3.21 %
5. AbbVie Inc
USA
5.53 %
6. Kinross Gold Corp
Canada
3.1 %
6. Gilead Sciences Inc
USA
4.66 %
7. Gold Fields ADR
Sør-Afrika
2.96 %
7. Amgen Inc
4.3 %
- 8. BioNTech SE
4.13 %
- 9. Karuna Therapeutics Inc
3.75 %
- 10. Royalty Pharma Plc
3.37 %

Listen over fondsbeholdning ble sist oppdatert 5 juni 2025.